Article
Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
JAMA cardiology - 1 Mar 2021
Greve Anders M, Christoffersen Mette, Frikke-Schmidt Ruth, Nordestgaard Børge G, Tybjærg-Hansen Anne
Abstract excerpt
Importance: Several lines of evidence support low plasma transthyretin concentration as an in vivo biomarker of transthyretin tetramer instability, a prerequisite for the development of both wild-type transthyretin cardiac amyloidosis (ATTRwt) and hereditary transthyretin cardiac amyloidosis (ATTRm). Both ATTRm and ATTRwt cardiac amyloidosis may manifest as heart failure (HF). However, whether low plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
